KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Sales (2016 - 2025)

Historic Return on Sales for Sarepta Therapeutics (SRPT) over the last 13 years, with Q3 2025 value amounting to 0.26%.

  • Sarepta Therapeutics' Return on Sales rose 1900.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.12% for FY2024, which is 5500.0% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Return on Sales stood at 0.26% for Q3 2025, which was up 1900.0% from 0.32% recorded in Q2 2025.
  • Sarepta Therapeutics' 5-year Return on Sales high stood at 0.32% for Q2 2025, and its period low was 2.04% during Q1 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.12% (2023), whereas its average is 0.34%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -15400bps in 2023, then surged by 21300bps in 2024.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Return on Sales stood at 0.61% in 2021, then increased by 30bps to 0.43% in 2022, then surged by 127bps to 0.11% in 2023, then skyrocketed by 110bps to 0.24% in 2024, then rose by 7bps to 0.26% in 2025.
  • Its Return on Sales stands at 0.26% for Q3 2025, versus 0.32% for Q2 2025 and 0.12% for Q1 2025.